Short answer · Medically reviewed summary · Last updated: 2026-05-08
The primary ICD-10 code for Congenital Adrenal Hyperplasia (CAH) is E25.0, representing congenital adrenal hyperplasia due to 21-hydroxylase deficiency, while the legacy ICD-9 code is 255.2. These codes are essential for medical documentation, insurance billing, and tracking the clinical management of patients living with this condition. What is the clinical significance of these CAH codes? Congenital Adrenal Hyperplasia (CAH) represents a group of autosomal recessive disorders characterized by impaired cortisol synthesis.
1 people with Congenital Adrenal Hyperplasia (CAH) have shared their first-person experience on this question at DiseaseMaps.
The primary ICD-10 code for Congenital Adrenal Hyperplasia (CAH) is E25.0, representing congenital adrenal hyperplasia due to 21-hydroxylase deficiency, while the legacy ICD-9 code is 255.2. These codes are essential for medical documentation, insurance billing, and tracking the clinical management of patients living with this condition.
Congenital Adrenal Hyperplasia (CAH) represents a group of autosomal recessive disorders characterized by impaired cortisol synthesis. Because Congenital Adrenal Hyperplasia (CAH) requires lifelong hormone replacement therapy, accurate coding is critical for coordinating care between pediatric endocrinologists and primary care providers. While E25.0 is the most frequent classification, other forms of Congenital Adrenal Hyperplasia (CAH) may utilize different sub-codes depending on the specific enzyme deficiency involved.
Yes, while the majority of cases are 21-hydroxylase deficiency, the classification system accounts for various enzymatic variations of Congenital Adrenal Hyperplasia (CAH). Clinicians use specific codes to differentiate between simple virilizing, salt-wasting, and non-classic forms of the disease:
Living with a chronic endocrine condition like Congenital Adrenal Hyperplasia (CAH) can feel isolating. At DiseaseMaps.org, 81 people with Congenital Adrenal Hyperplasia (CAH) have joined our community to share their experiences, symptom management strategies, and emotional support. Connecting with others who understand the daily burden of medication adherence is a vital step in managing the psychological aspects of this rare disease.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always consult with your healthcare provider regarding your specific medical condition.